MedPath

DIAMOX SEQUELS

DIAMOX SEQUELS

Discontinued
DIN Number

02238073

Drug Class

Human

Market Date

Dec 23, 1998

Company
HC

wyeth canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02238073
AIG Number0107512002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EC01 ACETAZOLAMIDE
Product Specifications
Dosage FormCapsule (Sustained-Release)
Route of AdministrationOral
AHFS Classification52:40.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

ACETAZOLAMIDEActive
Strength: 500 MG
Monograph: ACETAZOLAMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.